Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.885 USD | +4.71% | +0.19% | -1.08% |
21/05 | CoStar Group has room for expansion | |
16/05 | Transcript : Outlook Therapeutics, Inc., Q2 2024 Earnings Call, May 16, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.08% | 176M | |
+68.32% | 62.86B | |
-1.06% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.34% | 26.46B | |
-22.04% | 18.9B | |
+4.30% | 12.67B | |
+24.15% | 12.27B | |
+28.22% | 12.07B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- HC Wainwright Adjusts Price Target on Outlook Therapeutics to $5 From $6, Maintains Buy Rating